Skip to main content
Caplight Logo









BendBio

BendBio

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://bendbio.com

Last Round

Growth Equity

Oct 11, 2022

Company Overview

BendBio operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Growth Equity round in October 2022.

BendBio is a biotechnology company that provides an inertial microfluidics platform for automated cell processing and cell therapy manufacturing.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

BendBio Comparables

Compare BendBio with similar companies based on industry and business-model similarity.

BendBio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MFX
79%
AcouSort AB
78%
Akadeum Life Sciences
77%
Book a demo to see all comparables

For institutional investors. Book with your work email.

BendBio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Growth EquityOct 11, 2022
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Kyle Smith

CTO & Co-Founder

Founding Team

For institutional investors. Book with your work email.

BendBio Investors

Notable investors and investment history

BendBio investors
InvestorRounds
QHP CapitalGrowth Equity

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 4, 2026

    Monthly visitors grew 156% MoM, reaching 764.

  • May 2, 2025

    Monthly visitors grew 405% MoM, reaching 1K.

Book a demo to see all signals

For institutional investors. Book with your work email.

BendBio Filings

Explore SEC and related filing metadata, where available.

BendBio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about BendBio's valuation, stock price, and market status.

Is BendBio a public or private company?

BendBio is a private company.

What is the current stock price of BendBio?

BendBio is a private company, so its shares have no public market price. Caplight tracks BendBio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is BendBio worth (valuation)?

Valuation information for BendBio is not publicly available.

Can I buy BendBio stock?

BendBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was BendBio's last funding round?

BendBio's most recent funding round was Growth Equity on October 11, 2022.

Who are the main investors in BendBio?

Key investors in BendBio include QHP Capital.

Will BendBio IPO soon?

No public IPO plans have been announced for BendBio.

How can I track BendBio secondary market activity?

Caplight tracks bids, offers, and trades in BendBio's shares on secondary markets.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range2
Year Founded2021
Last FundingOct 11, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?